XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Note 3 - Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Notes Tables  
Disaggregation of Revenue [Table Text Block]
   

Three months ended

   

Nine months ended

 
   

September 30, 2025

   

September 30, 2024

   

September 30, 2025

   

September 30, 2024

 
   

(Unaudited)

   

(Unaudited)

 

Legacy FitLife

  $ 12,855     $ 13,512     $ 40,400     $ 42,229  

MusclePharm

    3,809       2,465       8,327       7,227  

Irwin

    6,821       -       6,821       -  

Total revenue

  $ 23,485     $ 15,977     $ 55,548     $ 49,456  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

Three months ended September 30,

   

Nine months ended September 30,

 
   

2025

   

2024

   

2025

   

2024

 
                                 

Basic weighted average shares outstanding

    9,391       9,196       9,332       9,196  

Dilutive effect of potential common shares

    606       734       630       690  

Diluted weighted average shares outstanding

    9,997       9,930       9,962       9,886  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
    As of September 30, 2025  
Description   Level 1     Level 2     Level 3     Total  
Liabilities:                                
Derivative liability – Cash flow hedge – variable-to-fixed interest rate swap   $ —     $ 32     $ —     $ 32  
Total liabilities at fair value   $ —     $ 32     $ —     $ 32